PTSD veterans develop hypertension at rates well above the civilian baseline. The cardiovascular research on chronic stress and blood pressure has been accumulating for forty years. And yet the VA rates hypertension at 10 percent for most veterans who get the grant at all, which puts the combined rating math in an awkward spot most filers don't think about until the decision letter lands.

That tension, between solid medical science and a rating schedule that gives you very little for it, is what I want to walk through. I pulled together what the published research says about PTSD and cardiovascular disease, what 38 CFR § 3.310 requires for a secondary claim, what 38 CFR § 4.104 demands at each rating tier, and what the practical value of the claim looks like once you do the combined ratings math. The medical case is strong, the rating schedule is stingy, and the value mostly shows up downstream when you're working a TDIU case or stacking secondaries toward 100 percent.

TL;DR

  • Hypertension secondary to PTSD has three documented medical pathways in the published research: sustained sympathetic nervous system activation driving chronic vasoconstriction, HPA axis dysregulation and cortisol elevation contributing to metabolic syndrome, and sleep disruption and apnea adding cardiovascular load.
  • The chain is governed by 38 CFR § 3.310, and both causation and aggravation are valid theories under Allen v. Brown.
  • Direct hypertension-secondary-to-PTSD isn't separately tagged in our aggregates, but two closely related secondary chains are. Across 666 hypertension-secondary-to-obesity cases, grants run at 17.7 percent, denials at 44.9 percent, and remands at 37.4 percent. Across 665 hypertension-secondary-to-sleep-apnea cases, grants run at 7.4 percent, with 52.9 percent dismissed and 31.6 percent remanded. The pattern holds in both: nexus quality is decisive. Strong nexus in the obesity chain grants at 93.0 percent across 57 cases; strong nexus in the sleep-apnea chain grants at 89.2 percent across 37 cases.
  • Hypertension rates 10, 20, 40, or 60 percent under 38 CFR § 4.104 DC 7101. Most granted cases land at 10 percent, which combined with 70 percent PTSD rounds back to 70 percent on the combined ratings table.
  • Even a 10 percent hypertension secondary still strengthens the overall claim profile for TDIU work, future stacking, and ancillary benefits eligibility, but it's not the high-dollar claim that sleep apnea or GERD secondaries can be.
What evidence wins a VA claimFree

Strong medical opinions won 89.7% of the time in our analysis. Weak ones won just 3.7%.

  • Know what makes a medical opinion harder to dismiss.
  • Use your own statement where it can carry real weight.
  • Catch common C&P exam problems before they hurt your claim.
Get the free guide

The Regulatory Framework: 38 CFR § 3.310 and Allen v. Brown

Causation vs aggravation

Secondary service connection lives under 38 CFR § 3.310. The regulation does two things. First, it allows service connection for a disability "proximately due to or the result of a service-connected disease or injury." That's causation. Second, since the Federal Circuit's decision in Allen v. Brown (7 Vet. App. 439, 1995), the regulation also recognizes aggravation, where a non-service-connected condition is made measurably worse by a service-connected one.

For causation, the veteran has to show the primary condition caused the secondary. For aggravation, the veteran has to show the primary condition made the secondary worse than its natural progression. Either theory can carry the claim.

How the framework applies to hypertension claims

For hypertension secondary to PTSD, both theories are usually in play. The Board has granted on direct causation, where a veteran with no pre-PTSD blood pressure history developed sustained hypertension after PTSD onset. It has also granted on aggravation, where a veteran had borderline or mild hypertension that became chronic and medication-dependent after PTSD diagnosis. The framework supports both routes. The problem is that the medical opinion attached to the claim often doesn't engage with the framework in a way that does the work it requires.

The Diagnostic Threshold: What 38 CFR § 4.104 Actually Requires

Before getting into pathways, I want to flag something in the rating schedule that trips up a lot of filers. Hypertension is rated under 38 CFR § 4.104, Diagnostic Code 7101. The note to that diagnostic code spells out a specific evidentiary requirement:

"Hypertension or isolated systolic hypertension must be confirmed by readings taken two or more times on at least three different days."

So the diagnostic predicate isn't just "the veteran's blood pressure is elevated." It's a documented pattern across at least three separate measurement days, with at least two readings per day. If the file doesn't show that, the rating doesn't attach even if the causation evidence is otherwise strong. I've seen claims denied at the rating decision specifically because the record had elevated readings on one or two days and the rater didn't find enough confirmation.

The 38 CFR § 4.104 rating tiers are:

  • 10 percent, with diastolic pressure predominantly 100 or more, or systolic pressure predominantly 160 or more, or with a history of diastolic pressure predominantly 100 or more requiring continuous medication for control
  • 20 percent, with diastolic pressure predominantly 110 or more, or systolic pressure predominantly 200 or more
  • 40 percent, with diastolic pressure predominantly 120 or more
  • 60 percent, with diastolic pressure predominantly 130 or more

The 10 percent tier is the one that catches most veterans. The 60 percent tier requires diastolic pressures so severe that most patients with that profile are in a hypertensive emergency long before the rating decision shows up. The granted cases I've seen cluster heavily at 10 percent, with occasional 20 percent ratings and very rare higher tiers.

Pathway One: PTSD Drives Chronic Sympathetic Activation and Vasoconstriction

This is the most direct of the three pathways and the one with the longest research history. PTSD is at the physiological level a disorder of arousal and threat response. The sympathetic nervous system runs hot. Heart rate variability decreases. Peripheral vascular resistance climbs. Over time, those changes drive measurable elevations in blood pressure.

The mechanism is well-understood. Sustained sympathetic activation triggers chronic vasoconstriction. Arterial walls undergo remodeling under that pressure. Endothelial function degrades. What started as a stress response becomes structural.

Coughlin (2011) published a meta-review on PTSD and cardiovascular disease pulling this literature together. PTSD populations carried elevated cardiovascular risk, including hypertension, at rates substantially above demographic-matched controls, with the relationship holding after adjusting for age, BMI, and traditional cardiovascular risk factors.

Edmondson (2013) and colleagues went into more detail on the autonomic and inflammatory pathways linking psychological trauma to vascular disease, documenting elevated catecholamines, sustained inflammation, and progressive vascular changes in PTSD populations. Kibler and colleagues have published on the PTSD-hypertension specific relationship in veteran samples, with consistent findings that veterans with PTSD develop hypertension earlier and at higher rates than veterans without PTSD.

The co-occurrence doesn't prove causation in any individual case. What it does is establish medical plausibility, which is the standard 38 CFR § 3.310 actually applies. The nexus letter doesn't have to prove the veteran's specific hypertension was caused by their specific PTSD. It has to show the proposition is at least as likely as not.

Pathway Two: HPA Axis Dysregulation, Cortisol, and Metabolic Syndrome

This pathway does the heavier lifting when the case involves weight gain, dyslipidemia, or pre-diabetes alongside the hypertension. PTSD dysregulates the hypothalamic-pituitary-adrenal axis. Cortisol patterns get disrupted. Glucose regulation slips. Lipid metabolism shifts. The downstream result is a metabolic profile that drives blood pressure up through multiple mechanisms simultaneously.

The published literature on PTSD and metabolic syndrome has been growing for fifteen years. The picture that's emerged is that PTSD isn't just psychiatric. It produces measurable changes in body composition, insulin sensitivity, and cardiovascular risk markers.

When this layers with the medication pathway, the case gets stronger. Veterans with PTSD are commonly prescribed SSRIs, SNRIs, atypical antipsychotics, or mood stabilizers, and several of those classes contribute to weight gain. The atypicals are particularly bad. Mirtazapine, when used for sleep, also produces substantial weight gain. The weight gain compounds the metabolic effects already driven by HPA dysregulation.

A C&P examiner who looks at a veteran with hypertension and says "this is essential hypertension, probably related to family history or weight" is usually skipping the metabolic syndrome pathway entirely. They see an endpoint and name a generic cause. The Board has granted when the private opinion does the work of explaining how PTSD, through HPA dysregulation and medication-induced metabolic changes, drove the blood pressure profile that ended up in the record. The Federal Circuit and CAVC have held that intermediate causal steps don't break the chain.

Pathway Three: Sleep Disruption, Sleep Apnea, and Cardiovascular Load

This pathway often shows up in tandem with a sleep apnea secondary claim, but it can carry a hypertension claim on its own even when sleep apnea hasn't been formally diagnosed.

PTSD disrupts sleep architecture. Veterans with PTSD show fragmented sleep, frequent arousals, reduced deep sleep, and elevated nocturnal sympathetic activity. Fragmented sleep alone is associated with daytime hypertension. When obstructive sleep apnea is layered on top, the cardiovascular load multiplies. Each apnea event triggers a sympathetic surge. Repeated nightly across years, the cumulative effect on blood pressure is substantial.

Untreated OSA is one of the most well-established secondary causes of resistant hypertension in the general population. In PTSD veterans, who already have higher baselines for both, the effect stacks.

This pathway also opens another legal route. If sleep apnea is already service-connected as secondary to PTSD, the hypertension can sometimes be claimed as tertiary, secondary to the secondary. The Board has granted on this kind of chain when the medical opinion makes the argument clearly.

The Typical Claim Pattern, and Why It Usually Fails

Here's how these cases tend to unfold. A veteran with an established PTSD rating gets diagnosed with hypertension during a primary care visit. The provider documents elevated readings across a couple of visits, prescribes lisinopril or losartan or HCTZ, and notes the diagnosis. The veteran files a secondary claim. The VA schedules a C&P exam.

The C&P examiner is usually not a cardiologist. They review the file, take a couple of readings, and write an opinion. The opinion is often two or three sentences. It says something like "the veteran's hypertension is less likely than not caused by his service-connected PTSD. Hypertension is primarily caused by genetic and lifestyle factors including diet, weight, age, and family history."

That gets the claim denied. The veteran appeals. Months or years later, the case lands at the BVA, where the judge looks at the same opinion and notices what's missing.

Successful appeals tend to involve a private opinion that does the work the C&P examiner didn't. The private opinion identifies one or more of the three pathways, cites supporting research, and explains how the pathway applies to this particular veteran. When the Board sees that kind of opinion next to a bare-bones C&P denial, it often grants.

The Board has been direct about what makes a medical opinion persuasive. From the PTSD analysis I did last year, the standard is: "A medical opinion is most probative if it is factually accurate, fully articulated, and based on sound reasoning."

A C&P opinion that names lifestyle or genetics without explaining why those factors are operative for this veteran, while ignoring the stress, metabolic, and sleep pathways, isn't "fully articulated" in the way the Board uses that phrase. It's a conclusion without a rationale.

What a Strong Nexus Letter Actually Looks Like

A strong nexus opinion in a hypertension secondary to PTSD case tends to do five things. It names both theories under 38 CFR § 3.310, causation and aggravation. It identifies one or more specific pathways. It cites the cardiovascular research, briefly, on sympathetic activation or HPA dysregulation or sleep-driven load. It applies that literature to the veteran's symptom timeline and medication history. And it anticipates and rebuts the common alternative explanations, particularly family history and lifestyle.

The cases that win at the Board tend to have nexus letters that read something like: "It is at least as likely as not that this veteran's hypertension is proximately due to or aggravated by his service-connected PTSD. The medical literature establishes that PTSD produces sustained sympathetic nervous system activation and HPA axis dysregulation, both documented contributors to chronic hypertension. This veteran developed hypertension following PTSD onset, with no documented elevated readings prior to PTSD diagnosis. His regimen includes [medications] which contribute to metabolic changes affecting cardiovascular function. Family history was reviewed and is non-contributory."

That's an opinion that engages with the framework. It cites literature, applies it to the individual, and rebuts the alternatives. Compare it to a typical C&P denial: "It is less likely than not that the veteran's hypertension is caused by his service-connected PTSD. Hypertension is multifactorial and primarily related to lifestyle, weight, and genetic factors." The first opinion does the work. The second one names a conclusion and stops.

I don't know the exact grant rate at the Board for hypertension secondary to PTSD specifically. But the closest proxies in our data point the same direction. In the hypertension-secondary-to-obesity cohort, strong nexus opinions granted at 93.0 percent across 57 cases versus 0.6 percent for weak opinions across 173. In the hypertension-secondary-to-sleep-apnea cohort, strong nexus granted at 89.2 percent across 37 cases versus 3.5 percent across 115 weak. Across the broader PTSD corpus of 1,640 cases, the same dynamic shows up: strong nexus opinions granted at 93.7 percent, versus 4.9 percent for weak opinions. There's no clean reason to think the hypertension-secondary-to-PTSD subset breaks the pattern.

Why This Claim Gets Denied More Than Sleep Apnea or GERD Secondaries

A few things about hypertension specifically make it harder to win than other PTSD secondaries.

First, the lifestyle and genetic confounder argument is more durable here. Family history of hypertension is common. Adult-onset weight gain is common. Salt-heavy diet is common. The C&P examiner can point at any of those and call it the cause without doing much work. The PTSD-hypertension literature is solid, but the alternative explanations are plausible enough to require active rebuttal in the nexus opinion.

Second, hypertension often doesn't require medication early. A veteran with diastolic pressures in the 90s might be monitored for years before getting on lisinopril. If the record shows elevated but untreated readings, the examiner can argue the condition isn't disabling enough to warrant a rating, even if causation is conceded.

Third, the absence of end-organ damage cuts against severity arguments. Many veterans with PTSD-driven hypertension have controlled blood pressure on medication, no left ventricular hypertrophy, no retinopathy, no kidney involvement. The clinical picture reads as "controlled essential hypertension," which the rater can read as not particularly severe.

The cases denied on these alternative explanations are usually the ones where the private opinion doesn't address them. The opinions that win anticipate the alternatives and rebut them head-on. I'm not in a position to tell anyone what their nexus letter should contain, that's not my role, but the pattern in winning cases is consistent.

The Combined Rating Math: Why 10 Percent Often Looks Like Zero

Here's where this claim differs from the other PTSD secondaries I've written about. The math doesn't move the needle the way sleep apnea or GERD secondaries do.

Why 70% + 10% rounds back to 70%

PTSD ratings under 38 CFR § 4.130 typically sit at 30, 50, 70, or 100 percent. For a veteran already at 70 percent PTSD, adding a 10 percent hypertension rating works out as follows on the VA combined ratings table. Take the larger rating first, 70 percent. The remaining capacity is 30 percent. The 10 percent hypertension takes 10 percent of that remaining 30 percent, which is 3 percent. 70 plus 3 is 73. The VA rounds to the nearest 10, which is 70.

So the combined rating doesn't change. The veteran goes from 70 percent PTSD to 70 percent PTSD with hypertension also rated at 10 percent, but the monthly compensation stays the same.

Where the strategic value actually shows up

That feels like the claim doesn't matter. It does, but not in the immediate compensation sense. Here's where the value shows up.

For TDIU work, the hypertension rating counts toward the analysis. A veteran with 70 percent PTSD plus 10 percent hypertension plus other secondaries has a stronger overall disability picture when the rater is deciding whether the veteran can maintain substantially gainful employment. If hypertension isn't service-connected, it's not in the picture at all.

For future stacking, the secondary preserves the claim if the condition worsens. If blood pressure becomes uncontrolled on multiple medications later, the rating can be increased without having to re-establish service connection. The chain is already locked in.

For combined ratings calculations across multiple secondaries, even small percentages add up. A veteran with 70 percent PTSD, 10 percent hypertension, 30 percent GERD secondary, 50 percent sleep apnea secondary, and a 20 percent musculoskeletal condition runs through the combined ratings table differently than the same veteran without the hypertension. The 10 percent isn't doing much alone, but it shifts the math in combination.

The honest framing: hypertension secondary to PTSD rarely produces a meaningful monthly bump on its own. It mostly matters in the context of a broader claim profile, especially TDIU work or stacking toward 100 percent.

Why This Matters Beyond the Individual Claim

The information asymmetry on this one is the inverse of what I usually see. The medical literature is well-developed. The cardiovascular research community treats PTSD as a cardiovascular risk factor. The pathways are documented in textbooks. What's missing is the practical understanding that the rating schedule doesn't translate the medical strength of the claim into meaningful monthly compensation for most veterans.

A veteran who reads about PTSD and cardiovascular disease and assumes the rating math works the same way as sleep apnea or GERD secondaries can be surprised when the decision letter comes back with a 10 percent rating that doesn't change the monthly check. That's a recoverable disappointment if they understand the strategic value of the claim, but it can be a frustrating moment if they expected a bigger bump.

That's the gap I built Claim Raven to close. Not just the medical pathways and the legal framework, but the practical math that determines whether a claim makes sense as a standalone or as part of a broader strategy. The medical case for hypertension secondary to PTSD is strong. The rating schedule is what it is. Knowing both, before the claim goes in, is how you avoid the surprise.

Bottom Line

Hypertension secondary to PTSD is one of the most medically defensible secondary claims in the VA system, backed by three documented pathways in the published research: chronic sympathetic activation, HPA dysregulation and metabolic syndrome, and sleep-driven cardiovascular load. The 38 CFR § 3.310 framework, combined with Allen v. Brown's recognition of aggravation, gives veterans two independent legal theories. The cases that fail typically fail on weak C&P opinions that name lifestyle or family history without addressing the cardiovascular literature. The cases that succeed at the Board tend to have private opinions that identify a specific pathway, cite supporting research, and rebut the alternatives. Where this claim differs from sleep apnea or GERD secondaries is in the combined rating math. Most granted hypertension secondaries land at 10 percent, which combined with 70 percent PTSD rounds back to 70 percent and doesn't change monthly compensation alone. The strategic value shows up in TDIU work, future stacking, and preserving the option to claim worsening severity later without re-litigating causation.

Methodology and Limitations

  • Data source: Claim Raven's analysis of 1,640 BVA decisions involving PTSD claims, with the hypertension secondary subset drawn from that pool. Medical literature references drawn from published research on PTSD and cardiovascular disease (Coughlin 2011 meta-review, Edmondson 2013, Kibler and colleagues on PTSD and hypertension in veteran samples).
  • Sample size: No direct hypertension-secondary-to-PTSD tag in the current aggregates. Nearest proxies are 666 hypertension-secondary-to-obesity cases (118 granted, 299 denied, 249 remanded) and 665 hypertension-secondary-to-sleep-apnea cases (49 granted, 47 denied, 210 remanded, 352 dismissed). The broader PTSD pool is 1,640 cases. * Classification approach: Cases were categorized by whether the secondary hypertension claim was granted, denied, or remanded, and by the nature of the medical evidence (C&P opinion only, private IME, or both).
  • Limitations:
  • These are cases that made it to the BVA. They don't represent all hypertension secondary claims. RO-level grants and unappealed denials aren't in this dataset.
  • Pathway classifications are based on what the Board cited. Cases where the mechanism wasn't elaborated may have involved any of the three pathways, or combinations.
  • Family history, weight, and dietary factors are real cardiovascular risk factors that can complicate the causal analysis. The data can't always disentangle PTSD-driven hypertension from coincident hypertension.
  • The rating math example uses 70 percent PTSD plus 10 percent hypertension. Different starting ratings produce different combined outcomes.
  • Medical literature citations are general references to research areas. Individual studies vary in methodology and effect size.
  • The 38 CFR § 4.104 documentation requirement (two readings on at least three different days) is a binary threshold. Cases that don't meet it can be denied at the rating stage independent of causation.
  • The Board's standard for what counts as a "strong" versus "weak" nexus opinion is somewhat subjective.

Disclaimer

I'm not accredited by VA, not a lawyer, not a VSO. This is data analysis, not claim advice. These are patterns from cases that made it to the BVA, they don't predict individual outcomes. If you need help with your claim, work with an accredited representative.

Where to go next

-Landon Founder, Claim Raven | U.S. Army Veteran